Diaceutics (LON:DXRX) Issues Earnings Results

Diaceutics (LON:DXRX) posted its earnings results on Tuesday. The company reported GBX 11 earnings per share (EPS) for the quarter, Digital Look Earnings reports. The company had revenue of GBX 3,844 million during the quarter. Diaceutics had a negative net margin of 4.42% and a negative return on equity of 3.94%.

Diaceutics Stock Down 9.7%

DXRX opened at GBX 148.92 on Tuesday. Diaceutics has a fifty-two week low of GBX 112.25 and a fifty-two week high of GBX 180. The company has a debt-to-equity ratio of 3.05, a quick ratio of 9.92 and a current ratio of 3.96. The company has a fifty day moving average of GBX 161.20 and a two-hundred day moving average of GBX 154.52. The stock has a market capitalization of £126.03 million, a price-to-earnings ratio of -82.73 and a beta of 0.92.

Diaceutics Company Profile

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.